https://consultorsalud.com/eeuu-lanzan-inhalador-pacientes-epoc/ 2022-05-12T16:35:26+00:00 https://consultorsalud.com/wp-content/uploads/2021/06/Lanzan-nuevo-inhalador-pacientes-EPOC.jpg https://consultorsalud.com/gilead-tratamiento-contra-el-vih/ 2022-05-12T16:35:10+00:00 https://consultorsalud.com/wp-content/uploads/2021/06/Gilead-pedira-aprobacion-a-la-FDA-de-su-tratamiento-inyectable-contra-el-VIH.jpg https://consultorsalud.com/antibiotico-para-ciertos-tipos-de-cancer/ 2022-05-12T16:35:05+00:00 https://consultorsalud.com/wp-content/uploads/2021/06/Antibiotico-muestra-eficacia-en-el-tratamiento-de-ciertos-tipos-de-cancer.jpg https://consultorsalud.com/farmaco-redujo-hospitalizacion-covid/ 2022-05-12T16:34:50+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/farmaco-redujo-hospitalizaciones-covid-moderado.jpg https://consultorsalud.com/medicamentos-aprobados-fda-junio-2021/ 2022-05-12T16:34:39+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Medicamentos-aprobados-por-la-FDA-en-junio-de-2021-%C2%BFQue-farmaceutica-lidera-las-aprobaciones.jpg https://consultorsalud.com/diagnosticar-la-insuficiencia-renal-aguda-pediatrica/ 2022-05-12T16:34:34+00:00 https://consultorsalud.com/wp-content/uploads/2021/06/Desarrollan-metodo-para-diagnosticar-la-insuficiencia-renal-pediatrica.jpg https://consultorsalud.com/fda-aprueba-medicamento-infecciones-vaginales/ 2022-05-12T16:34:23+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/fda-aprueba-medicamento-infecciones-vaginales-hongos.jpg https://consultorsalud.com/antidepresivos-no-afectan-el-desarrollo-embarazo/ 2022-05-12T16:34:22+00:00 https://consultorsalud.com/wp-content/uploads/2021/06/Estudio-muestra-que-los-antidepresivos-no-afectan-el-desarrollo-del-embarazo.jpg https://consultorsalud.com/fda-aprueba-finerenona-retrasar-erc/ 2022-05-12T16:33:58+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/fda-aprueba-finerenona-erc-diabetes-tipo-2.jpg https://consultorsalud.com/eli-lilly-acuerdo-insulina-experimental/ 2022-05-12T16:33:47+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/eli-lilly-fortalece-portafolio-insulina-experimental.jpg https://consultorsalud.com/jot-dx-el-monitor-cardiaco-insertable/ 2022-05-12T16:33:15+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/Jot-Dx-el-monitor-cardiaco-insertable-que-identifica-ritmos-cardiacos-anormales.jpg https://consultorsalud.com/medica-experimental-enfermedad-renal-cronica/ 2022-05-12T16:32:52+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Medicamento-experimental-podria-tratar-la-enfermedad-renal-cronica-y-la-diabetes-tipo-2.jpg https://consultorsalud.com/pfizer-y-eli-lilly-tratamientos-para-alopecia/ 2022-05-12T16:32:48+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/Pfizer-y-Eli-Lilly-tras-el-mercado-de-farmacos-para-la-alopecia-.jpg https://consultorsalud.com/microbiota-vaginal-para-vaginitis/ 2022-05-12T16:32:36+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Transferencia-de-microbiota-vaginal-ayudaria-a-tratar-la-vaginitis-.jpg https://consultorsalud.com/oxford-inicia-ensayo-clinico-vih/ 2022-05-12T16:32:27+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Oxford-inicia-ensayo-vacuna-VIH.jpg https://consultorsalud.com/ganancias-biontech-vacuna-covid-2021/ 2022-05-12T16:32:23+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/18.672-millones-de-dolares-ganara-BioNTech-por-su-vacuna-contra-el-Covid-en-2021.jpg https://consultorsalud.com/no-antibioticos-resistencia-antimicrobiana/ 2022-05-12T16:32:11+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/No-solo-los-antibioticos-contribuyen-a-crear-resistencia-antimicrobiana-.jpg https://consultorsalud.com/hiperlipidemia-2-farmacos-control/ 2022-05-12T16:31:57+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Combinacion-de-dos-farmacos-serian-claves-para-tratar-la-hiperlipidemia.jpg https://consultorsalud.com/medicamento-trigliceridos-riesgo-ictus/ 2022-05-12T16:31:46+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/medicamento-reducir-trigliceridos-ictus.jpg https://consultorsalud.com/desabastecimiento-de-tocilizumab/ 2022-05-12T16:31:45+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/OMS-alerta-sobre-desabastecimiento-de-tocilizumab.jpg https://consultorsalud.com/la-ema-y-la-fda-los-dos-que-mas-difieren/ 2022-05-12T16:31:31+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/La-EMA-y-la-FDA-difieren-en-la-aprobacion-de-medicamentos-.jpg https://consultorsalud.com/logran-eliminar-el-cancer-metastasico-de-rat/ 2022-05-12T16:31:29+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Cientificos-logran-eliminar-el-cancer-metastasico-de-ratones.jpg https://consultorsalud.com/vih-reto-para-la-farmaindustria/ 2022-05-12T16:31:11+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/VIH-la-vacuna-que-representa-el-mayor-reto-para-la-farmaindustria-.jpg https://consultorsalud.com/aprobaciones-de-la-fda-agosto-de-2021/ 2022-05-12T16:30:55+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/Estos-son-los-medicamentos-y-tecnologias-que-aprobo-la-FDA-en-agosto-2021.jpg https://consultorsalud.com/arnm-de-biontech-contra-el-cancer/ 2022-05-12T16:30:32+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/El-tratamiento-basado-en-ARNm-de-BioNTech-contra-el-cancer-da-sus-primeros-resultados.jpg https://consultorsalud.com/abbvie-invierte-370-millones-de-dolares/ 2022-05-12T16:29:56+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/Abbvie-invierte-370-millones-de-dolares-en-terapia-genica-para-enfermedades-de-la-vista.jpg https://consultorsalud.com/5-medicamentos-cuya-patente-clave-se-vence/ 2022-05-12T16:29:41+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/15-medicamentos-a-los-que-se-les-vencen-las-patentes-antes-del-2030.jpg https://consultorsalud.com/uis-grandes-avances-en-investigacion/ 2022-05-12T16:29:37+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/UIS-avances-investigacion-epoc-covid-19.jpg https://consultorsalud.com/medicamentos-cuya-patente-vence/ 2022-05-12T16:29:29+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/5-medicamentos-cuya-patente-clave-se-vence-antes-del-2030-Parte-2.jpg https://consultorsalud.com/dolutegravir-para-ninos-con-vih/ 2022-05-12T16:29:28+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Tratamiento-antirretroviral-con-dolutegravir-muestra-mejores-resultados-en-ninos-con-VIH-.jpg https://consultorsalud.com/pfizer-distrofia-muscular-de-duchenne/ 2022-05-12T16:29:15+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/Pfizer-avanza-con-una-terapia-genica-para-la-distrofia-muscular-de-Duchenne.jpg https://consultorsalud.com/antibioticos-podrian-ayudar-a-tratar-melanomas/ 2022-05-12T16:29:13+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Antibioticos-podrian-ayudar-a-tratar-los-melanomas-.jpg https://consultorsalud.com/el-cabotegravir-de-gsk-podria-ser-prep/ 2022-05-12T16:29:01+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/El-Cabotegravir-de-GSK-podria-servir-como-tratamiento-preventivo-de-accion-prolongada-del-VIH.jpg https://consultorsalud.com/sanofi-abandona-la-carrera-covid-19/ 2022-05-12T16:28:51+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Sanofi-abandona-la-carrera-Covid-19-pero-continua-con-desarrollos-basados-en-ARNm.jpg https://consultorsalud.com/diabetes-gestacional-metformina-podria-usarse/ 2022-05-12T16:28:44+00:00 https://consultorsalud.com/wp-content/uploads/2021/07/Farmaco-oral-muestra-mejores-beneficios-que-la-insulina-en-diabetes-gestacional.jpg https://consultorsalud.com/mercado-de-antivirales-orales-para-covid/ 2022-05-12T16:28:32+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Mercado-de-antivirales-orales-para-el-Covid-19-%C2%BFrealmente-funcionan-.jpg https://consultorsalud.com/desarrollan-tratamiento-oral-fibromas/ 2022-05-12T16:28:29+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/tratamiento-oral-efectivo-fibromas-uterinos.jpg https://consultorsalud.com/naloxona-muertes-sobredosis-de-opioides/ 2022-05-12T16:28:19+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/La-naloxona-podria-prevenir-muertes-por-sobredosis-de-opioides-.jpg https://consultorsalud.com/aprueban-terapia-car-t-leucemia-adultos/ 2022-05-12T16:28:15+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/aprueban-nueva-terapia-car-t-para-la-leucemia-en-adultos.jpg https://consultorsalud.com/upadacitinib-de-abbvie-dermatitis-atopica/ 2022-05-12T16:28:08+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/Upadacitinib-de-AbbVie-mostro-buenos-resultados-en-el-tratamiento-de-la-dermatitis-atopica.jpg https://consultorsalud.com/oms-vacuna-contra-la-malaria-de-gsk/ 2022-05-12T16:28:04+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/La-OMS-aprobo-la-vacuna-contra-la-malaria-de-GSK-%C2%BFComo-se-beneficiara-la-farmaceutica-.jpg https://consultorsalud.com/uso-antibioticos-dermatitis-atopica-ninos/ 2022-05-12T16:27:59+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/uso-temprano-de-antibioticos-y-relacion-con-dermatitis-atopica.jpg https://consultorsalud.com/inv-pistas-vacunas-intranasales-gripe/ 2022-05-12T16:27:47+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/investigacion-brinda-pistas-vacunas-intranasales-gripe.jpg https://consultorsalud.com/roche-comprara-terapia-genica-epilepsia/ 2022-05-12T16:27:44+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Roche-compro-una-terapia-genica-para-la-epilepsia-por-mas-de-3285-millones-de-dolares.jpg https://consultorsalud.com/promisoria-terapia-genica-trast-neurologico/ 2022-05-12T16:27:26+00:00 https://consultorsalud.com/wp-content/uploads/2021/08/promisoria-terapia-genica-trastorno-neurologico.jpg https://consultorsalud.com/analizan-ventajas-y-desventajas-del-prep/ 2022-05-12T16:27:08+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/Analizan-ventajas-y-desventajas-del-PrEP-oral-diario-Vs-inyectable-en-VIH.jpg https://consultorsalud.com/farmaco-alzheimer-de-roche-terapia-innovadora/ 2022-05-12T16:27:05+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Medicamento-para-el-Alzheimer-de-Roche-recibe-designacion-de-terapia-innovadora-por-parte-de-la-FDA-.jpg https://consultorsalud.com/antidepresivos-inhibieron-tumores-cancer/ 2022-05-12T16:26:55+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/Antidepresivos-inhibieron-el-crecimiento-de-tumores-cancerigenos-en-ratones.jpg https://consultorsalud.com/ventas-por-aducanumab-tercer-trimestre-2021/ 2022-05-12T16:26:45+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Biogen-cierra-el-tercer-trimestre-con-USD300.000-en-ventas-por-Aducanumab-su-medicamento-para-el-Alzheimer-1-2.jpg https://consultorsalud.com/padres-bebes-trastorno-autista-tea-sintomas/ 2022-05-12T16:26:44+00:00 https://consultorsalud.com/wp-content/uploads/2021/09/padres-de-bebes-con-TEA-ralentizar-sintomas-con-intervencion-dirigida.jpg https://consultorsalud.com/vacuna-moderna-prevenir-covid-19-ninos/ 2022-05-12T16:26:27+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Vacuna-Moderna-si-ayudaria-a-prevenir-la-covid-19-en-ninos.jpg https://consultorsalud.com/biopsia-liquida-detecta-cancer-de-mama/ 2022-05-12T16:26:24+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Biopsia-liquida-podria-detectar-casos-de-cancer-de-mama-con-mal-pronostico-.jpg https://consultorsalud.com/eli-lilly-medicamento-para-el-alzheimer/ 2022-05-12T16:26:14+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Eli-Lilly-busca-anticipar-la-llegada-de-su-medicamento-para-el-Alzheimer-al-mercado.jpg https://consultorsalud.com/nuevo-tratamiento-oral-para-la-tuberculosis/ 2022-05-12T16:26:07+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Establecen-nuevo-regimen-de-tratamiento-mas-eficaz-para-la-tuberculosis-farmacorresistente.jpg https://consultorsalud.com/buscan-tratar-el-asma-grave/ 2022-05-12T16:25:49+00:00 https://consultorsalud.com/wp-content/uploads/2021/10/Con-anticuerpos-monoclonales-buscan-tratar-el-asma-grave.jpg https://consultorsalud.com/pfizer-preve-36-000-millones-ventas-vacuna/ 2022-05-12T16:25:48+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/Pfizer-preve-ventas-US36-mil-millones-vacuna-covid.jpg https://consultorsalud.com/temocilina-eliminacion-bacterias-resistentes/ 2022-05-12T16:25:38+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/Temocilina-muestra-eficacia-en-la-eliminacion-de-bacterias-intestinales-resistentes-.jpg https://consultorsalud.com/gilead-sciences-y-merck-tratamientos-para-vih/ 2022-05-12T16:25:32+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/Gilead-Sciences-y-Merck-buscan-nuevos-horizontes-en-tratamientos-para-VIH.jpg https://consultorsalud.com/vacuna-cancer-de-mama-triple-negativo/ 2022-05-12T16:25:25+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/Ensayan-vacuna-experimental-contra-el-cancer-de-mama-triple-negativo.jpg https://consultorsalud.com/novo-nordisk-mercado-obesidad-2021/ 2022-05-12T16:25:20+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/Novo-Nordisk-impulsada-por-sus-medicamentos-para-la-obesidad-sigue-liderando-este-mercado-en-2021.jpg https://consultorsalud.com/aumento-costo-de-desarrollo-medicamentos/ 2022-05-12T16:25:02+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/El-costo-para-desarrollar-un-medicamento-se-doblo-en-los-ultimos-10-anos.jpg https://consultorsalud.com/boehringer-ingelheim-cartera-en-oncologia/ 2022-05-12T16:24:48+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/Boehringer-Ingelheim-busca-ampliar-su-cartera-en-oncologia-con-nueva-adquisicion-.jpg https://consultorsalud.com/pfizer-permitira-la-fabricacion-de-su-pildora/ 2022-05-12T16:24:31+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/Pfizer-permitira-la-fabricacion-de-su-pildora-anticovid-como-generico-en-95-paises.jpg https://consultorsalud.com/diabetes-tipo-2-biomarcador-19-anos/ 2022-05-12T16:24:18+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/follistatina-posible-biomarcador-diabetes-tipo-2.jpg https://consultorsalud.com/anemia-en-pacientes-con-enfermedad-renal/ 2022-05-12T16:23:51+00:00 https://consultorsalud.com/wp-content/uploads/2021/12/Desarrollan-compuesto-para-tratar-la-anemia-en-pacientes-con-enfermedad-renal-cronica.jpg https://consultorsalud.com/detectan-nueva-hormona-diabetes-1-y-2/ 2022-05-12T16:23:40+00:00 https://consultorsalud.com/wp-content/uploads/2021/12/Detectan-hormona-clave-en-casos-de-diabetes-1-y-2.jpg https://consultorsalud.com/fda-keytruda-pembrolizumab-cancer-rinon/ 2022-05-12T16:23:31+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/fda-aprueba-uso-de-keytruda-pembrolizumab-en-cancer-de-rinon.jpg https://consultorsalud.com/medicamento-para-acondroplasia-de-biomarin/ 2022-05-12T16:23:19+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/El-medicamento-para-el-enanismo-de-BioMarin-recibio-la-aprobacion-de-la-FDA.jpg https://consultorsalud.com/dicerna-pharmaceuticals-adquisicion-novo-nordisk/ 2022-05-12T16:23:03+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/Dicerna-Pharmaceuticals-la-ultima-adquisicion-de-Novo-Nordisk-por-3.300-millones-de-dolares.jpg https://consultorsalud.com/dolutegravir-mejor-tratamiento-para-vih/ 2022-05-12T16:22:42+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Dolutegravir-mejoraria-la-eficacia-de-los-tratamientos-estandar-contra-el-VIH-segun-estudio-.jpg https://consultorsalud.com/biontech-prepara-vacuna-variante-omicron/ 2022-05-12T16:22:36+00:00 https://consultorsalud.com/wp-content/uploads/2021/11/biontech-prepara-vacuna-variante-omicron-moderna-jj.jpg https://consultorsalud.com/grupo-de-farmacos-cancer-de-utero-agresivo/ 2022-05-12T16:22:30+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Grupo-de-farmacos-pueden-ralentizar-el-progreso-del-cancer-de-utero-agresivo-.jpg https://consultorsalud.com/presentan-metodo-test-medicamentos-oncologicos/ 2022-05-12T16:22:16+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/presentan-metodo-para-testear-medicamentos-oncologicos.jpg https://consultorsalud.com/en-debate-primer-farmaco-hiperinsomnia-idiopatica/ 2022-05-12T16:22:04+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/En-debate-primer-farmaco-aprobado-para-la-hiperinsomnia-idiopatica.jpg https://consultorsalud.com/cancer-de-prostata-terapia-hormonal/ 2022-05-12T16:21:55+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Hombres-con-cancer-de-prostata-podrian-beneficiarse-con-terapia-hormonal-anadida-a-la-radioterapia-.jpg https://consultorsalud.com/pfizer-inicia-ensayo-clinico-vacuna-omicron/ 2022-05-12T16:21:37+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Pfizer-y-BioNTech-inician-ensayo-clinico-de-su-vacuna-contra-omicron.jpg https://consultorsalud.com/7-de-10-medicamentos-son-primeros-de-clase/ 2022-05-12T16:21:29+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/7-de-cada-10-medicamentos-en-desarrollo-clinico-son-los-primeros-de-su-clase.jpg https://consultorsalud.com/inmunoterapia-cancer-revierte-latencia-vih/ 2022-05-12T16:21:18+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Inmunoterapia-contra-el-cancer-revierte-la-latencia-del-VIH.jpg https://consultorsalud.com/impacto-marihuana-durante-el-embarazo/ 2022-05-12T16:21:08+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Publican-el-estudio-mas-grande-sobre-el-impacto-del-uso-de-marihuana-durante-el-embarazo.jpg https://consultorsalud.com/arnm-regeneracion-de-huesos/ 2022-05-12T16:19:56+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/ARNm-prometedor-para-la-regeneracion-de-huesos.jpg https://consultorsalud.com/combinacion-farmacologica-cancer-de-prostata/ 2022-05-12T16:19:46+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Nueva-combinacion-farmacologica-muestra-eficacia-en-el-tratamiento-de-cancer-de-prostata-metastasico-y-hormonosensible.jpg https://consultorsalud.com/sanofi-adquiere-la-biotecnologica-origimm/ 2022-05-12T16:19:41+00:00 https://consultorsalud.com/wp-content/uploads/2021/12/Sanofi-adquiere-la-biotecnologica-Origimm-para-desarrollar-una-vacuna-contra-el-acne-.jpg https://consultorsalud.com/novartis-prepara-varios-lanzamientos-para-2026/ 2022-05-12T16:19:22+00:00 https://consultorsalud.com/wp-content/uploads/2021/12/Ante-vencimiento-de-patentes-Novartis-prepara-20-lanzamientos-para-2026.jpg https://consultorsalud.com/nubeqa-de-bayer-para-cancer-de-prostata/ 2022-05-12T16:19:09+00:00 https://consultorsalud.com/wp-content/uploads/2021/12/Buenos-resultados-de-Nubeqa-de-Bayer-para-cancer-de-prostata-metastasico-en-ensayos-de-fase-3.jpg https://consultorsalud.com/estudio-estatinas-podrian-retrasar-la-metastasis/ 2022-05-12T16:18:57+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Estudio-estatinas-podrian-retrasar-la-metastasis-de-celulas-cancerosas.jpg https://consultorsalud.com/rinvoq-de-abbvie-enfermedad-de-crohn/ 2022-05-12T16:18:55+00:00 https://consultorsalud.com/wp-content/uploads/2021/12/Rinvoq-de-Abbvie-podria-convertirse-en-el-primer-inhibidor-para-la-enfermedad-de-Crohn.jpg https://consultorsalud.com/descubrimiento-terapia-diabetes-tipo-1/ 2022-05-12T16:18:41+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Descubrimiento-acercaria-el-tratamiento-oral-para-la-diabetes-tipo-1.jpg https://consultorsalud.com/pfizer-empieza-a-invertir-las-ganancias/ 2022-05-12T16:18:36+00:00 https://consultorsalud.com/wp-content/uploads/2021/12/Pfizer-empieza-a-invertir-las-ganancias-que-obtuvo-por-la-venta-de-su-vacuna-anticovid.jpg https://consultorsalud.com/proteina-implicada-enfermedades-neurodegenerat/ 2022-05-12T16:18:32+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Identifican-proteina-implicada-en-multiples-enfermedades-neurodegenerativas.jpg https://consultorsalud.com/wp-content/uploads/2022/03/modelo.jpg https://consultorsalud.com/eli-lilly-presentara-alzheimer-fda/ 2022-05-12T16:18:24+00:00 https://consultorsalud.com/wp-content/uploads/2021/12/Eli-Lilly-apresura-la-presentacion-de-su-medicamento-contra-el-Alzheimer-.jpg https://consultorsalud.com/aducanumab-mitad-precio-alzheimer/ 2022-05-12T16:18:03+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Aducanumab-Biogen-reduce-a-la-mitad-el-precio-de-su-medicamento-para-el-Alzheimer-.jpg https://consultorsalud.com/cambios-sobre-uso-cannabis-epilepsia-resistent/ 2022-05-12T16:17:58+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Proponen-nuevas-orientaciones-para-el-uso-de-cannabis-en-epilepsia-resistente.jpg https://consultorsalud.com/aumento-precio-400-medicamentos-eeuu/ 2022-05-12T16:17:50+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Inicia-el-2022-con-el-aumento-de-precio-de-400-medicamentos-en-Estados-Unidos-.jpg https://consultorsalud.com/riesgos-del-uso-de-marihuana-medicinal-estudio/ 2022-05-12T16:17:44+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/%C2%BFCuales-son-los-riesgos-del-uso-de-marihuana-medicinal-Estudio.jpg https://consultorsalud.com/sanofi-colaboracion-medicamento-parkinson/ 2022-05-12T16:17:25+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Sanofi-entra-en-un-acuerdo-de-colaboracion-para-desarrollar-un-medicamento-para-el-Parkinson-.jpg https://consultorsalud.com/combinacion-de-farmacos-frena-cancer-de-mama/ 2022-05-12T16:17:19+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Medicamento-frena-el-avance-de-un-tipo-de-cancer-de-mama-en-el-758-de-pacientes.jpg https://consultorsalud.com/reino-unido-antibioticos-sinteticos-bajo-costo/ 2022-05-12T16:17:07+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/En-Reino-Unido-crearon-antibioticos-sinteticos-de-bajo-costo-y-de-gran-potencial.jpg https://consultorsalud.com/nuevos-medicamentos-bristol-myers-squibb/ 2022-05-12T16:16:59+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Cartera-de-nuevos-medicamentos-de-Bristol-Myers-Squibb-podria-generar-25-mil-millones-para-2029.jpg https://consultorsalud.com/eli-lilly-diabetes-y-alzheimer-2022/ 2022-05-12T16:16:48+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Eli-Lilly-centrara-sus-esfuerzos-este-ano-en-diabetes-y-Alzheimer.jpg https://consultorsalud.com/medicamento-vih-cancer-colorrectal/ 2022-05-12T16:16:47+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Medicamento-para-VIH-muestra-eficacia-en-el-tratamiento-del-cancer-colorrectal.jpg https://consultorsalud.com/abbvie-mercado-fibrosis-quistica/ 2022-05-12T16:16:31+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/AbbVie-esta-tras-el-duro-mercado-de-la-fibrosis-quistica-.jpg https://consultorsalud.com/acido-tranexamico-reduce-riesgo-hemorragia/ 2022-05-12T16:16:14+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Acido-tranexamico-reduciria-el-riesgo-de-hemorragias-en-cirugias-de-riesgo-cardiovascular.jpg https://consultorsalud.com/27-fabricantes-de-genericos-pildora-de-merck/ 2022-05-12T16:16:05+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/27-fabricantes-de-genericos-suministraran-pildora-Merck.jpg https://consultorsalud.com/vacunas-ganancias-84-000-millones/ 2022-05-12T16:15:48+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Vacunas-Covid-19-dejaran-ganancias-de-mas-de-USD-84.000-millones-para-los-grandes-fabricantes-.jpg https://consultorsalud.com/abbott-ventas-historicas-en-2021/ 2022-05-12T16:15:34+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Abbott-reporto-ventas-historicas-en-2021-43.000-millones-de-dolares.jpg https://consultorsalud.com/companias-buscan-vacuna-contra-el-vih/ 2022-05-12T16:15:09+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/Dos-companias-buscan-desarrollar-una-vacuna-contra-el-VIH-basadas-en-la-tecnologia-ARNm-y-CRISPR.jpg https://consultorsalud.com/medicamento-detener-el-crecimiento-de-tumores/ 2022-05-12T16:15:07+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Identifican-medicamento-capaz-de-detener-el-crecimiento-de-tumores-cerebrales-recurrentes.jpg https://consultorsalud.com/eli-lilly-dos-nuevas-plantas-de-fabricacion/ 2022-05-12T16:14:52+00:00 https://consultorsalud.com/wp-content/uploads/2022/01/A-puertas-de-sus-nuevos-lanzamientos-Eli-Lilly-invierte-mas-de-445-millones-en-una-nueva-planta-de-produccion.jpg https://consultorsalud.com/estos-son-los-medicamentos-que-la-fda/ 2022-05-12T16:14:39+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Estos-son-los-medicamentos-que-la-FDA-aprobo-en-enero.jpg https://consultorsalud.com/remdesivir-supero-5600-millones-en-ventas/ 2022-05-12T16:14:23+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Remdesivir-de-Gilead-supero-los-1.400-millones-en-ventas-en-2021.jpg https://consultorsalud.com/beneficios-por-la-venta-de-leqvio-en-2022/ 2022-05-12T16:14:12+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Novartis-espera-positivos-beneficios-por-la-venta-de-Leqvio-en-2022.jpg https://consultorsalud.com/medicamentos-mas-esperados-en-2022/ 2022-05-12T16:13:51+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Top-10-medicamentos-mas-esperados-en-2022.jpg https://consultorsalud.com/sanofi-enfermedades-raras-medicamento/ 2022-05-12T16:13:40+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Sanofi-se-consolida-en-el-mercado-de-enfermedades-raras-con-nuevo-medicamento-.jpg https://consultorsalud.com/merck-acuerdos-para-desarrollar-farmacos/ 2022-05-12T16:13:05+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Merck-firma-acuerdo-con-una-biotecnologica-britanica-para-desarrollar-nuevas-moleculas-en-oncologia-y-neurologia.jpg https://consultorsalud.com/vraylar-para-el-trastorno-depresivo-mayor-recaudaria-4-mil-millones-en-ventas-abbvie/ 2022-05-12T16:11:15+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Vraylar-para-el-trastorno-depresivo-mayor-recaudaria-4-mil-millones-en-ventas-en-2022-AbbVie.jpg https://consultorsalud.com/bavencio-para-carcinoma-urotelial/ 2022-05-12T16:11:01+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/Bavencio-de-Merck-muestra-buenos-resultados-en-ensayos-de-fase-3-para-carcinoma-urotelial.jpg https://consultorsalud.com/biomarin-proyecciones-de-ventas-2022/ 2022-05-12T16:10:41+00:00 https://consultorsalud.com/wp-content/uploads/2022/02/BioMarin-publica-sus-proyecciones-totales-de-ventas-para-2022.jpg https://consultorsalud.com/ensayos-clinicos-que-no-2021-part1/ 2022-05-12T16:10:19+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Top-10-ensayos-clinicos-que-no-dieron-resultado-en-2021.jpg https://consultorsalud.com/fda-aprobacion-ultrarrapida-opdivo/ 2022-05-12T16:08:11+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/FDA-otorga-aprobacion-ultrarrapida-a-Opdivo-de-Bristol-Myers-Squibb-para-tratar-el-cancer-de-pulmon-de-celulas-no-pequenas.jpg https://consultorsalud.com/ensayos-clinicos-sin-resultado-2/ 2022-05-12T16:07:58+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/5-ensayos-clinicos-que-no-dieron-resultado-en-2021-%E2%80%93-parte-2.jpg https://consultorsalud.com/aprobaciones-fda-febrero-2022/ 2022-05-12T16:07:42+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Estos-son-los-medicamentos-que-la-FDA-aprobo-en-febrero-de-2022.jpg https://consultorsalud.com/europa-54-nuevos-medicamentos-2021/ 2022-05-12T16:07:29+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Cifra-record-Europa-aprobo-54-nuevos-medicamentos-en-2021.jpg https://consultorsalud.com/rinvoq-de-abbvie-para-colitis-ulcerosa/ 2022-05-12T16:07:11+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Rinvoq-de-AbbVie-logra-su-su-tercer-nuevo-uso-en-4-meses-FDA-lo-aprobo-para-tratar-la-colitis-ulcerosa.jpg https://consultorsalud.com/biogen-nuevos-datos-de-eficacia-de-aduhelm/ 2022-05-12T16:06:53+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Biogen-publica-nuevos-datos-de-eficacia-de-Aduhelm-para-el-Alzheimer.jpg https://consultorsalud.com/fda-aprobaciones-marzo-2022/ 2022-05-12T16:05:53+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/FDA-aprobaciones-del-regulador-norteamericano-en-marzo-2022.jpg https://consultorsalud.com/glaxosmithkline-refuerza-oncologia/ 2022-05-12T16:04:52+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/GlaxoSmithKline-amplia-su-segmento-de-oncologia-con-nueva-adquisicion.jpg https://consultorsalud.com/roche-ganancias-primer-trimestre-2022/ 2022-05-12T16:04:34+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Roche-la-mejor-en-ganancias-en-el-primer-trimestre-del-2022.jpg https://consultorsalud.com/primer-trimestre-para-biomarin-2022/ 2022-05-12T16:03:49+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Excelente-primer-trimestre-para-BioMarin-impulsado-por-su-exito-para-la-acondroplasia.jpg https://consultorsalud.com/198-millones-recaudo-wegovy-novo-nordisk/ 2022-05-12T16:03:31+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/198-millones-de-dolares-recaudo-Wegovy-de-Novo-Nordisk-solo-en-el-primer-trimestre-2022.jpg https://consultorsalud.com/wp-content/uploads/2022/05/image.png https://consultorsalud.com/hospital-julio-mendez-barreneche-interv-2023/ 2022-05-12T15:43:21+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Una-vez-mas-prorrogan-intervencion-al-Hospital-Julio-Mendez-Barreneche.jpg https://consultorsalud.com/renovacion-auto-registro-sanitario-d334/ 2022-05-12T15:26:44+00:00 https://consultorsalud.com/wp-content/uploads/2022/03/Renovacion-automatica-de-registro-sanitario-actualizacion-de-la-normatividad-farmacologica-colombiana-Decreto-334-de-2022.jpg https://consultorsalud.com/eps-por-la-aplicacion-de-pruebas-covid-19/ 2022-05-12T14:57:01+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/%C2%BFCuanto-le-reconoceran-a-cada-EPS-por-la-aplicacion-de-pruebas-Covid-19.jpg https://consultorsalud.com/senado-no-logro-proteger-aborto-estados-unidos/ 2022-05-12T14:54:03+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Senado-no-logro-proteger-el-derecho-al-aborto-en-Estados-Unidos.jpg https://consultorsalud.com/colombia-desp-suicidio-medicamente-asistido/ 2022-05-12T14:14:45+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Colombia-despenaliza-el-suicidio-medicamente-asistido-SMA.jpg https://consultorsalud.com/avance-medico-en-reumatologia/ 2022-05-11T19:57:17+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Innovacion-y-ciencia-la-respuesta-del-avance-medico-en-reumatologia.jpg https://consultorsalud.com/pfizer-adquiere-biohaven-2022/ 2022-05-11T19:32:23+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Pfizer-adquiere-Biohaven-por-USD-11.600-millones-la-gigante-norteamericana-incursiona-en-el-mercado-de-la-migrana.jpg https://consultorsalud.com/wp-content/uploads/2022/05/fighting-for-a-slice-of.jpeg https://consultorsalud.com/reino-unido-guias-ia-tecnologia-sanitaria/ 2022-05-11T17:21:51+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Reino-Unido-publica-guias-sobre-IA-en-tecnologia-sanitaria.jpg https://consultorsalud.com/confianza-en-el-sector-salud/ 2022-05-11T17:08:30+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Confianza-en-el-sector-salud.jpg https://consultorsalud.com/mex-encrucijada-por-el-uso-ludico-del-cannabis/ 2022-05-11T16:01:43+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Mexico-en-una-encrucijada-por-el-uso-medicinal-y-ludico-del-cannabis.jpg https://consultorsalud.com/joel-candia-briceno-ratificado-viceministro-sal/ 2022-05-11T15:38:43+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Joel-Candia-Briceno-sera-el-viceministro-de-Salud-Publica.jpg https://consultorsalud.com/decreto-distrital-183-pico-y-placa-talento-hum/ 2022-05-11T14:44:03+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Decreto-Distrital-183-Levantan-pico-y-placa-para-el-talento-humano-en-salud.jpg https://consultorsalud.com/armas-principal-causa-de-muerte-eeuu/ 2022-05-11T14:35:44+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Lesiones-por-armas-son-ahora-la-principal-causa-de-muerte-entre-los-ninos-y-jovenes-estadounidenses.jpg https://consultorsalud.com/wp-content/uploads/2022/05/Causa-de-muerte.jpeg https://consultorsalud.com/tendencias-de-costos-medicos-latam-2022/ 2022-05-11T13:49:48+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Estas-son-las-tendencias-de-costos-medicos-en-Latinoamerica-en-2022.jpg https://consultorsalud.com/wp-content/uploads/2022/05/factores-de-riesgo-latinoamerica-AON.jpg https://consultorsalud.com/wp-content/uploads/2022/05/riesfos-america-latina-AON.jpg https://consultorsalud.com/medicina-prepagada-servicios-de-salud-magisteri/ 2022-05-10T22:15:46+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Empresas-de-medicina-prepagada-podran-prestar-servicios-de-salud-al-magisterio-y-otros-actores-del-regimen-de-excepcion.jpg https://consultorsalud.com/senado-estadounidense-votara-aborto-ley/ 2022-05-10T17:53:12+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/En-medio-de-polemicas-Senado-estadounidense-votara-sobre-el-aborto.jpg https://consultorsalud.com/diferencias-geneticas-hermanos-entorno-social/ 2022-05-10T16:41:12+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Diferencias-geneticas-entre-hermanos-dependen-del-entorno-social.jpg https://consultorsalud.com/la-obesidad-llega-al-estatus-de-epidemia-en-eu/ 2022-05-10T16:29:23+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/La-obesidad-llega-al-estatus-de-epidemia-en-Europa.jpg https://consultorsalud.com/sistema-de-salud-inyeccion-de-recursos/ 2022-05-10T15:24:07+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Sistema-de-salud-recibio-inyeccion-de-recursos-para-mantener-acciones-contra-el-covid-19.jpg https://consultorsalud.com/peru-actualiza-entrega-equipos-biomedicos-emerg/ 2022-05-10T15:23:18+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Peru-actualiza-requisitos-de-entrega-de-equipos-biomedicos-a-pacientes.jpg https://consultorsalud.com/reembolso-entre-las-arl-y-las-eps/ 2022-05-10T15:11:45+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Reembolso-entre-las-ARL-y-las-EPS-%C2%BFComo-se-hara-el-proceso-Proyecto-de-decreto.jpg https://consultorsalud.com/supersalud-gestiona-recursos-antioquia-bogota/ 2022-05-10T14:43:24+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Supersalud-gestiona-recursos-para-hospitales-de-Antioquia-y-Bogota.jpg https://consultorsalud.com/hitos-ministerio-de-salud-lider-fernando-ruiz/ 2022-05-09T21:27:48+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Cuales-son-los-grandes-hitos-que-alcanzo-el-Ministerio-de-Salud-en-cabeza-de-Fernando-Ruiz-Entrevista.jpg https://consultorsalud.com/ucrania-denuncia-destruccion-mas-400-hospitales/ 2022-05-09T20:19:16+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Ucrania-denuncia-atentados-a-medicos-y-destruccion-de-mas-de-400-hospitales-1.jpg https://consultorsalud.com/mexico-contratara-500-medicos-cubanos/ 2022-05-09T18:03:28+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Por-deficit-de-especialistas-Mexico-contratara-500-medicos-cubanos.jpg https://consultorsalud.com/tienes-dudas-mipres-3-0-webinario/ 2022-05-09T17:38:57+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/%C2%BFTienes-dudas-sobre-MIPRES-3.0-Revisa-ahora-nuestro-webinario.jpeg https://consultorsalud.com/investigacion-y-desarrollo-crecio-11/ 2022-05-09T17:08:19+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Inversion-en-Investigacion-y-Desarrollo-ID-de-la-industria-farmaceutica-crecio-en-un-11-en-2021.jpg https://consultorsalud.com/wp-content/uploads/2022/05/image-8.png https://consultorsalud.com/irregularidades-giros-subsidios-sisben/ 2022-05-09T15:56:17+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Contraloria-hallan-irregularidades-en-giros-de-subsidios-del-Sisben.jpg https://consultorsalud.com/enfermedad-renal-cronica-pandemia-col/ 2022-05-09T15:25:17+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/%C2%BFComo-se-gestiono-el-cuidado-de-la-Enfermedad-Renal-Cronica-durante-la-pandemia-en-Colombia.jpg https://consultorsalud.com/wp-content/uploads/2022/05/image-6.png https://consultorsalud.com/wp-content/uploads/2022/05/image-7.png https://consultorsalud.com/estos-serian-mecanismos-de-seguimiento-dec-441/ 2022-05-09T15:11:09+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/%C2%BFCuales-seran-los-mecanismos-de-seguimiento-a-los-acuerdos-de-voluntades.jpg https://consultorsalud.com/declar-autorizan-cuarta-dosis-en-colombia/ 2022-05-06T21:06:33+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Gobierno-autoriza-cuarta-dosis-en-Colombia-para-mayores-de-50-anos.jpg https://consultorsalud.com/guillermo-grosso-dadivas-contratos-cancer/ 2022-05-06T20:26:38+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Acusan-a-Guillermo-Grosso-expresidente-de-Cafesalud-de-recibir-dadivas-por-contratos-oncologicos.jpg https://consultorsalud.com/desequilibrio-financiero-saludvida-2022/ 2022-05-06T18:14:25+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Otra-mas-SaludVida-EPS-declara-desequilibrio-financiero-e-imposibilidad-de-pagar-sus-deudas.jpg https://consultorsalud.com/wp-content/uploads/2022/05/image-1.png https://consultorsalud.com/wp-content/uploads/2022/05/image-3.png https://consultorsalud.com/wp-content/uploads/2022/05/image-2.png https://consultorsalud.com/wp-content/uploads/2022/05/image-4.png https://consultorsalud.com/wp-content/uploads/2022/05/image-5.png https://consultorsalud.com/cancer-de-ovario-enfermedad-silenciosa-mortal/ 2022-05-06T17:20:49+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Cancer-de-ovario-enfermedad-silenciosa-y-mortal-en-Colombia.jpg https://consultorsalud.com/argentina-ths-aumento-salarial-del-59/ 2022-05-06T16:43:54+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Argentina-para-hacerle-frente-a-la-inflacion-los-trabajadores-de-la-salud-tendran-un-aumento-salarial-del-59.jpg https://consultorsalud.com/salud-mental-empeora-prolongacion-pandemia/ 2022-05-06T16:32:59+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Salud-mental-empeora-con-la-continuidad-de-la-pandemia.jpg https://consultorsalud.com/medicamentos-fda-en-abril-2022/ 2022-05-06T15:15:20+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Medicamentos-aprobados-por-la-FDA-en-abril-2022.jpg https://consultorsalud.com/continua-excepcion-al-pico-y-placa-talento-hum/ 2022-05-06T14:40:00+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Este-2-de-mayo-se-elimina-la-excepcion-al-pico-y-placa-para-el-talento-humano-en-salud.jpg https://consultorsalud.com/decreto-681-2022-estrat-de-envejecimiento-col/ 2022-05-06T14:19:06+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Decreto-681-de-2022-Politica-de-envejecimiento-y-vejez-en-Colombia.jpg https://consultorsalud.com/fda-limita-uso-vacuna-janssen-covid-19/ 2022-05-06T14:16:07+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/FDA-limita-el-uso-de-la-vacuna-Janssen-contra-covid-19.jpg https://consultorsalud.com/muertes-por-covid-2021-2022/ 2022-05-05T21:54:13+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Estimaciones-de-la-OMS-muestran-que-la-pandemia-ocasiono-149-millones-de-muertes-en-el-mundo-entre-2020-y-2021.jpg https://consultorsalud.com/inflacion-precio-de-medicamentos-mex/ 2022-05-05T20:07:45+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Inflacion-en-Mexico-impacta-el-precio-de-los-medicamentos.jpg https://consultorsalud.com/fda-autoriza-metodo-diagnostico-alzheimer/ 2022-05-05T20:02:09+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/FDA-autoriza-metodo-diagnostico-para-alzheimer-en-fase-temprana.jpg https://consultorsalud.com/washington-registra-peor-brote-tuberculosis/ 2022-05-05T16:53:57+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Washington-registra-su-peor-brote-de-tuberculosis-en-20-anos.jpg https://consultorsalud.com/iets-metodologia-para-fijar-precio-de-venta/ 2022-05-05T15:36:34+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/IETS-Lista-la-metodologia-para-fijar-el-precio-de-venta-de-nuevos-medicamentos-con-la-evaluacion-de-valor-terapeutico-y-economico.jpg https://consultorsalud.com/peru-actualiza-competencias-profesion-salud/ 2022-05-05T14:12:21+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Peru-actualizo-competencias-de-profesiones-del-sector-salud.jpg https://consultorsalud.com/union-europea-lanza-interoperabilidad-en-salud/ 2022-05-04T17:27:16+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Union-Europea-lanza-plataforma-de-interoperabilidad-en-el-sector-salud.jpg https://consultorsalud.com/cali-apuesta-hospitales-sostenibles-medio-amb/ 2022-05-04T14:44:22+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Cali-implementa-el-programa-%E2%80%98Hospitales-Seguros-Saludables-y-Sostenibles.jpg https://consultorsalud.com/estados-unidos-perderia-derecho-aborto/ 2022-05-03T17:55:19+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Estados-Unidos-perderia-el-derecho-al-aborto.jpg https://consultorsalud.com/borrador-plan-decenal-de-salud-publica-20222031/ 2022-05-03T17:53:31+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Conozca-el-borrador-del-Plan-Decenal-de-Salud-Publica-2022-2031.jpg https://consultorsalud.com/para-el-2023-estaria-listo-el-hospital-de-usme/ 2022-05-03T16:24:50+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Para-el-2023-estaria-listo-el-hospital-de-Usme-en-Bogota.jpg https://consultorsalud.com/fenutssa-salud-paro-indefinido/ 2022-05-03T16:17:30+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/FENUTSSA-Arequipa-entra-en-paro-indefinido.jpg https://consultorsalud.com/compartiran-acceso-a-los-datos-de-enfermedades/ 2022-05-03T15:01:58+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Habra-acceso-a-la-informacion-de-las-Enfermedades-Ruinosas-y-Catastroficas-de-Alto-Costo-en-Colombia.jpg https://consultorsalud.com/colombia-politica-publica-envejecimiento-vejez/ 2022-05-03T14:48:47+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Colombia-tendra-su-primera-politica-de-envejecimiento-y-vejez-1.jpg https://consultorsalud.com/ventanilla-unica-empresarial-tramites-salud/ 2022-05-03T13:43:48+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Afiliacion-a-EPS-podra-hacerse-desde-la-Ventanilla-Unica-Empresarial-Minsalud.jpg https://consultorsalud.com/reportan-alto-nivel-mortalidad-sepsis-neonatal/ 2022-05-02T20:24:03+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Reportan-altos-niveles-de-mortalidad-por-sepsis-neonatal-en-el-mundo.jpg https://consultorsalud.com/hallan-la-causa-genetica-del-lupus/ 2022-05-02T19:50:49+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Hallan-la-causa-genetica-del-lupus.jpg https://consultorsalud.com/revive-webinario-decreto-441-de-2022/ 2022-05-02T18:04:46+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Revive-ahora-el-webinario-sobre-el-Decreto-441-de-2022.jpeg https://consultorsalud.com/sin-presupuesto-cambios-salud-mental-mex/ 2022-05-02T17:05:14+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Cambios-en-el-modelo-de-salud-mental-de-Mexico-se-ejecutara-sin-presupuesto-adicional.jpg https://consultorsalud.com/tarifas-de-contribucion-solidaria-2022/ 2022-05-02T15:44:44+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/Tarifas-de-contribucion-solidaria-seran-segun-el-grupo-del-Sisben-conozcalas.jpg https://consultorsalud.com/eps-familiar-de-colombia-sistema-salud/ 2022-05-02T13:40:03+00:00 https://consultorsalud.com/wp-content/uploads/2022/05/EPS-Familiar-de-Colombia-entra-al-sistema-de-salud-del-pais.jpg https://consultorsalud.com/dengue-onqoy-casos-enfermedad-peru/ 2022-05-02T12:41:50+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/%C2%A1Dengue-Onqoy-app-que-monitorea-casos-de-dengue-en-Peru.jpg https://consultorsalud.com/hospital-universitario-san-ignacio-80-anos/ 2022-04-29T20:15:26+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Hospital-Universitario-San-Ignacio-celebra-80-anos-de-labores.jpg https://consultorsalud.com/wp-content/uploads/2022/04/Hospital-Universitario-San-Ignacio-en-sus-inicios.jpg https://consultorsalud.com/smartphone-camara-detectar-enferm-neurologicas/ 2022-04-29T20:12:55+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Una-camara-de-smartphone-seria-suficiente-para-detectar-trastornos-neurologicos.jpg https://consultorsalud.com/wp-content/uploads/2022/04/smartphone-pupila.jpg https://consultorsalud.com/emergencia-sanitaria-30-jun-2022/ 2022-04-29T19:55:02+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Extienden-la-emergencia-sanitaria-hasta-el-30-de-junio-pero-tendra-nuevas-condiciones-Res.-666-de-2022.jpg https://consultorsalud.com/cuenta-de-alto-costo-ips-gestion-riesgo/ 2022-04-29T19:23:57+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Cuenta-de-Alto-Costo-premio-a-las-IPS-con-mejor-gestion-de-riesgo.jpg https://consultorsalud.com/intervencion-hospital-san-rafael-2022/ 2022-04-28T21:00:31+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Hospital-San-Rafael-de-Leticia-estara-un-ano-mas-bajo-intervencion-de-la-Supersalud.jpg https://consultorsalud.com/pfizer-autorizacion-dosis-de-refuerzo-ninos/ 2022-04-28T20:34:21+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Pfizer-solicita-autorizacion-de-su-dosis-de-refuerzo-para-ninos-hasta-los-11-anos.jpg https://consultorsalud.com/giro-directo-al-cancer-infantil-dec-647-de-2022/ 2022-04-28T19:12:44+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Reglamentado-el-giro-directo-a-los-prestadores-por-atenciones-en-cancer-infantil-Dec.-647-de-2022.jpg https://consultorsalud.com/minsa-proyecto-digitalizacion-sis/ 2022-04-28T18:41:12+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/Minsa-presento-proyecto-de-digitalizacion-del-SIS.jpg https://consultorsalud.com/eps-lideres-enfermedades-de-alto-costo/ 2022-04-28T17:38:42+00:00 https://consultorsalud.com/wp-content/uploads/2022/04/EPS-lideres-en-el-manejo-de-enfermedades-de-alto-costo.jpg